Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing and treating cerebral apoplexy

A composition and stroke technology, applied in the directions of drug combinations, active ingredients of hydroxyl compounds, pharmaceutical formulations, etc., can solve the problems of difficult quality control and standardized production, complex composition, poor safety, etc., and achieve convenient standardized production and controllable quality. , the effect of reducing the degree of edema

Active Publication Date: 2021-12-24
GUANGZHOU BAIYUNSHAN PHARMA HLDG CO LTD BAIYUNSHAN PHARMA GENERAL FACTORY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these pharmaceutical compositions often have single efficacy, complex composition, or poor safety, and lack strict and systematic pharmacodynamic experiments that meet the requirements of modern pharmacology, making it difficult to carry out strict quality control and standardized production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing and treating cerebral apoplexy
  • Pharmaceutical composition for preventing and treating cerebral apoplexy
  • Pharmaceutical composition for preventing and treating cerebral apoplexy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The test drug of this embodiment experimental group is made up of the following components by weight:

[0030]

[0031]

Embodiment 2

[0033] The test drug of this embodiment experimental group is made up of the following components by weight:

[0034]

Embodiment 3

[0036] The test drug of this embodiment experimental group is made up of the following components by weight:

[0037]

[0038]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for preventing and treating cerebral apoplexy. The composition comprises the following components of ginseng, radix aconiti carmichaeli, lucid ganoderma, safflower carthamus, artificial musk, bear gall, pearl, venenum bufonis, borneol and calculus bovis. The composition can obviously improve neurological impairment, relieve the degree of encephaledema and reduce the area of cerebral infarction, and the effect is possibly related to the medicine for relieving oxidative stress and protecting brain tissues from being damaged by oxygen free radicals.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for preventing and treating stroke. Background technique [0002] Stroke is a common disease in neurology. It is often caused by the sudden rupture of blood vessels in the brain or the inability of blood to flow into the brain due to vascular obstruction, which causes brain tissue damage. It has the characteristics of high morbidity, high mortality and high disability rate. A factor of death. In recent years, due to the increasing pressure of life and work, the incidence of stroke has been increasing year by year and tends to be younger. Stroke includes ischemic stroke and hemorrhagic stroke, and the incidence of ischemic stroke is relatively high, accounting for about 75% to 90% of the total number of strokes. Ischemic stroke usually occurs in a quiet state, manifested as dysphagia, slurred articulation, crooked corners of the mouth, dys...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/714A61P9/10A61P25/00A61P39/00A61K35/618A61K35/65A61K35/55A61K35/413A61K31/045
CPCA61K36/258A61K36/714A61K36/074A61K36/286A61K35/55A61K35/413A61K35/618A61K35/65A61K31/045A61P9/10A61P25/00A61P39/00A61K2300/00
Inventor 王玮王健松廖弈秋黄海文罗志波张琳
Owner GUANGZHOU BAIYUNSHAN PHARMA HLDG CO LTD BAIYUNSHAN PHARMA GENERAL FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com